CCMB to validate Covid-19 testing reagents and kits

Our Bureau Hyderabad | Updated on April 13, 2020 Published on April 13, 2020

CSIR-Centre for Cellular and Molecular Biology, Hyderabad has been identified by the Indian Council of Medical Research (ICMR) to be one of the five validation centres for Covid-19 testing in India.

CSIR-CCMB is the only non-ICMR lab to be a part of these Centres of Excellence that will validate the non-US FDA, and non-EUA/CE-IVD approved kits for Covid-19 testing.

This move comes as a welcome step as the number of Covid-19 testing in India needs to be ramped up. Lack of kits developed and imported from other countries necessitates India to build its own testing kits. While multiple start-ups and life science companies across the country have been already identified for their ability to develop such kits, they would need to be quickly validated.

These Centres of Excellence will be crucial in their validation, and approval for use for the testing centres in the country.

“Since Mar 31, 2020 CCMB has been a testing centre for Covid-19, and has been working with hospitals across 33 districts of Telangana. It has also trained medical doctors and staff from government hospitals in the state. This new responsibility of kit validation will now enable us to support the healthcare and life science industry sector to bring all stakeholders together in this fight against Covid-19”, Rakesh Mishra, Director, CCMB, said in a statement.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 13, 2020
This article is closed for comments.
Please Email the Editor